Endo Pharmaceuticals Inc. v. Actavis, Inc.
Court of Appeals for the Federal Circuit
1Opinion of the Court
MOORE, Circuit Judge.
Endo Pharmaceuticals, Inc. (Endo) appeals from the district court’s order denying its motions for a preliminary injunction to prevent Roxane Laboratories, Inc. (Roxane), Actavis Inc., and Actavis South Atlantic LLC (Actavis) from marketing and selling their respective generic drug products during the pendency of this litigation. Because the district court erred in concluding that Roxane and Actavis (Ap-pellees) had an implied license to practice the asserted patents, and because Appel-lees do not have an express license, we vacate and remand.
Background
Endo sells Opana®…
2Cases cited8 opinions
- Wang Laboratories, Inc. v. Mitsubishi Electronics America, Inc. And Mitsubishi Electric Corporation, Defendants/cross-AppellantsCourt of Appeals for the Federal Circuit · 1997
- Sanofi-Synthelabo v. Apotex, Inc.Court of Appeals for the Federal Circuit · 2006
- Spindelfabrik Suessen-Schurr Stahlecker & Grill Gmbh v. Schubert & Salzer Maschinenfabrik Aktiengesellschaft and Schubert & Salzer MacHine Works, Inc.Court of Appeals for the Federal Circuit · 1987
- Transcore v. Electronic Transaction Consultants Corp.Court of Appeals for the Federal Circuit · 2009
- Amp Incorporated v. The United StatesUnited States Court of Claims · 1968
3 more not listed; retrieve them via the Exa API.
3Cited by16 opinions
- Verinata Health, Inc. v. Ariosa Diagnostics, Inc.Court of Appeals for the Federal Circuit · 2016
- Silver Buckle Mines, Inc. v. United StatesUnited States Court of Federal Claims · 2017
- Amgen Inc. v. Apotex Inc.Court of Appeals for the Federal Circuit · 2016
- Cascades Av LLC v. Evertz Microsystems Ltd.District Court, E.D. Illinois · 2018
- Cascades AV LLC v. Evertz Microsystems, Ltd.District Court, N.D. Illinois · 2018
11 more not listed; retrieve them via the Exa API.